Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of down syndrome patients

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 1, 2007, Pages 43-48

  Hamurcu, Zuhal ^a   Demirtas, Halil ^a   Patiroglu, Turkan ^a   Kumandas, Sefer ^a   Imamoglu, Nalan ^a   Ozkul, Yusuf ^a   Donmez Altuntas, Hamiyet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Aging; Down syndrome; Flow cytometry; NORs; RNA content; Trisomy 21

Indexed keywords

MITOGENIC AGENT; PHYTOHEMAGGLUTININ; RNA;

ADOLESCENT; ADULT; AGE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA ANALYSIS; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; MALE; MITOGENS; PHYTOHEMAGGLUTININS; RNA;

EID: 33846223257     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20139     Document Type: Article

References (35)

1. Gardiner K, Fortna A, Bechtel L, Davisson MT. Mouse models of Down syndrome: How useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 2003;318:137-147.
2. Sumner AT. Nucleolar organizers (NORs). In: Sumner AT, editor. Chromosome Banding. London: Unwin Hyman; 1990. pp 187-205.
3. Hernandez-Verdun D, Louvet E. Le nucleole: Structure, functions et maladies associées. Med Sci (Paris) 2004;20:37-44.
4. Caburet S, Conti C, Schurra C, Lebofsky R, Edelstein SJ, Bensimon A. Human ribosomal RNA gene arrays display a broad range of palindromic structures. Genome Res 2005;15:1079-1085.
5. Demirtas H, Imamoglu N, Cucer N, Donmez H, Yilmaz A, Candemir Z, Bokesoy I. NOR (rDNA) expression enhancement in phytohemagglutinin-stimulated lymphocytes of Down syndrome patients. Erciyes Univ J Health Sci 1999;8:24-27.
6. Demirtas H, Imamoglu N, Donmez H, Cucer N, Yilmaz A, Candemir Z. Condensed chromatin surface and NORs surface enhancement in mitogen- stimulated lymphocytes of Down syndrome patients. Ann Génét 2001;44:77-82.
7. Imamoglu N, Demirtas H, Ilten A. NOR expression increases in interphase lymphocytes of Down syndrome babies/children as AgNORs surface, according to the mitogen concentration in the culture medium. Micron 2006;37:129-133.
8. Imamoglu N, Demirtas H, Donmez-Altuntas H, Ilten A. Higher NORs-expression in lymphocyte of trisomy 21 babies/children: In vivo evaluation. Micron 2005;36:503-507.
9. Imamoglu N, Demirtas H, Donmez-Altuntas H, Hamurcu Z, Ilten A. NORs expression increases on metaphase chromosomes of Down syndrome lymphocytes, in concordance with the mitogen concentration in the culture medium. Cytometry B Clin Cytom 2005;66: 36-39.
10. Darzynkiewicz Z. Simultaneous analysis of cellular RNA and DNA content. In: Darzynkiewicz Z, Robinson JP, Crissman HA, editors. Methods in Cell Biology, Vol. 41. San Diego, CA: Academic Press; 1994. pp 401-420.
11. Hamurcu Z, Demirtas H, Kumandas S. Flow cytometric comparison of RNA content in peripheral blood mononuclear cells of Down syndrome patients and control individuals. Cytometry B Clin Cytom 2006;70:24-28.
12. Toba K, Winton EF, Koike T, Shibata A. Simultaneous three color analysis of surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. J Immunol Methods 1995;182: 193-207.
13. Steck K, El-Naggar A. Simultaneous DNA/RNA analysis of solid and hematoreticular malignancies. In: Jarazeski MJ, Heller R, editors. Methods in Molecular Biology, Flow Cytometry Protocols, Vol. 91. Totawa, NJ: Humana Press; 1988. pp 167-180.
14. Traganos F, Dazynkiewicz Z, Sharpless T, Melamed MR. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluoremetric system. J Histochem Cytochem 1977;25:46-56.
15. Darzynkiewicz Z. DNA-RNA differential staining using AO. In: Paul Robinson J, editor. Handbook of Flow Cytometry Methods. USA: Wiley; 1993. pp 114-115.
16. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. London: Prentice-Hall; 1990. p 56.
17. Shim KS, Bergelson JM, Furuse M, Ovod V, Krude T, Lubec G. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain. J Neural Transm Suppl 2003;67:117-128.
18. Cheon MS, Kim SH, Yaspo ML, Blasi F, Aoki Y, Melen K, Lubec G. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain, Part 1: Challenging the gene dosage effect hypothesis. Amino Acids 2003;24:111-117.
19. Cheon MS, Shim KS, Kim SH, Hara A, Lubec G. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain, Part 4: Challenging the gene dosage effect hypothesis. Amino Acids 2003;25:41-47.
20. Harris-Cerruti C, Kamsler A, Kaplan B, Lamb B, Segal M, Groner Y. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein. Eur J Neurosci 2004;19:1174-1190.
21. Ferrando-Miguel R, Cheon MS, Lubec G. Protein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain, Part 5: Overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5). Amino Acids 2004;26:255-261.
22. Antonarakis SE, Lyle R, Chrast R, Scott HS. Differential gene expression studies to explore the molecular pathophysiology of Down syndrome. Brain Res Rev 2001;36:265-274.
23. McQuillan CI, Choo KH. Comparison of total cellular DNA, mRNA, and rRNA levels between normal and Down syndrome patients. J Inherit Metab Dis 1992;15:112-120.
24. Borsatto B, Simith MAC. Reduction of the activity of ribosomal genes with age in Down's syndrome. Gerontology 1996;42:147-154.
25. Derenzini M. The AgNORs. Micron 2000;31:117-120.
26. Trerè D. AgNOR staining and quantification. Micron 2000;31:127-131.
27. Park E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin Immunot 2000; 95:62-69.
28. Franceschi C, Licastro F, Chiricolo M, Bonetti F, Zannotti M, Fabris N, Mocchegiani E, Fantini MP, Paolucci P, Masi M. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J Immunol 1981;126:2161-2164.
29. Chiricolo M, Minelli L, Licastro F, Tabacchi P, Zannotti M, Franceschi C. Alteration of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects. Gerontology 1984;30:145-152.
30. Franceschi C, Chiricolo M, Chiricolo M, Zannotti M, Masi M, Mocchegiani E, Fabris N. Oral zinc supplementation in Down's syndrome: Restoration of thymic endocrine activity and of some immune defects. J Ment Defic Res 1988;32:169-181.
31. Licastro F, Melotti C, Parante R, Davis LJ, Chiricolo M, Zannotti M, Barboni F. Derangement of non-specific immunity in Down syndrome subjects: Low leukocyte chemiluminescence activity after phagocytic activation. Am J Med Genet Suppl 1990;7:242-246.
32. Licastro F, Mariani RA, Faldella G, Carpenè E, Guidicini G, Rangoni A, Grilli T, Bazzocchi G. Immune-endocrine status and celiac disease in children with Down's syndrome: Relationship with zinc and cognitive efficiency. Brain Res Bull 2001;55:313-317.
33. Corsi MM, Ponti W, Venditti A, Ferrara F, Baldo C, Chiappelli M, Licastro F. Proapoptotic activated T-cells in the blood of children with Down's syndrome: Relationship with dietary antigens and intestinal alterations. Int J Tissue React 2003;25:117-125.
34. da Silva AMA, PayaÕ SLM, Borsatto B, Bertolucci PHF, Smith MAC. Quantitative evaluation of rRNA in Alzheimer's disease. Mech Ageing Dev 2000;120:57-64.
35. Weerkamp F, de Haas EFE, Naber BAE, Comans-Bitter WM, Bogers AJJC, van Dongen JJM, Staal FJT. Age-related changes in the cellular composition of the thymus in children. J Allergy Clin Immunol 2005;115:834-840.